Microbial lipopolysaccharide‐induced inflammation contributes to cognitive impairment and white matter lesion progression in diet‐induced obese mice with chronic cerebral hypoperfusion
CNS Neuroscience & Therapeutics · 2023
DOI: 10.1111/cns.14301 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2023. Verfasst von Toshiki Inaba und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: White Matter, Cognitive Dysfunction, Brain Ischemia, Carotid Stenosis. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Aims
White matter lesions (WMLs) are involved in the pathological processes leading to cognitive decline and dementia. We examined the mechanisms underlying the exacerbation of ischemia‐induced cognitive impairment and WMLs by diet‐induced obesity, including lipopolysaccharide (LPS)‐triggered neuroinflammation via toll‐like receptor (TLR) 4.
Methods
Wild‐type (WT) and TLR4‐knockout (KO) C57BL/6 mice were fed a high‐fat diet (HFD) or low‐fat diet (LFD), and subjected to bilateral carotid artery stenosis (BCAS). Diet groups were compared for changes in gut microbiota, intestinal permeability, systemic inflammation, neuroinflammation, WML severity, and cognitive dysfunction.
Results
In WT mice, HFD induced obesity and increased cognitive impairment and WML severity compared with LFD‐fed mice following BCAS. HFD caused gut dysbiosis and increased intestinal permeability, and plasma LPS and pro‐inflammatory cytokine concentrations. Furthermore, HFD‐fed mice had higher LPS levels and higher neuroinflammatory status, including increased TLR4 expression, in WMLs. In TLR4‐KO mice, HFD also caused obesity and gut dysbiosis but did not increase cognitive impairment or WML severity after BCAS. No difference was found between HFD‐ and LFD‐fed KO mice for LPS levels or inflammatory status in either plasma or WMLs.
Conclusion
Inflammation triggered by LPS–TLR4 signaling may mediate obesity‐associated exacerbation of cognitive impairment and WMLs from brain ischemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
- Department of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.
- Department of Neurology, University of Yamanashi, Yamanashi, Japan.
- Metagen Inc., Yamagata, Japan.
Förderung
- JSPS KAKENHI
Zitieren
APA
Inaba, T., Yamashiro, K., Kurita, N., Ueno, Y., Miyamoto, N., Hira, K., Nakajima, S., Kijima, C., Nakaguro, R., Urabe, T., & Hattori, N. (2023). Microbial lipopolysaccharide‐induced inflammation contributes to cognitive impairment and white matter lesion progression in diet‐induced obese mice with chronic cerebral hypoperfusion. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14301
Vancouver
Inaba T, Yamashiro K, Kurita N, Ueno Y, Miyamoto N, Hira K, et al. Microbial lipopolysaccharide‐induced inflammation contributes to cognitive impairment and white matter lesion progression in diet‐induced obese mice with chronic cerebral hypoperfusion. CNS Neuroscience & Therapeutics. 2023. doi:10.1111/cns.14301
BibTeX
@article{Inaba2023,
author = {Inaba, Toshiki and Yamashiro, Kazuo and Kurita, Naohide and Ueno, Yuji and Miyamoto, Nobukazu and Hira, Kenichiro and Nakajima, Sho and Kijima, Chikage and Nakaguro, Ryohei and Urabe, Takao and Hattori, Nobutaka},
title = {Microbial lipopolysaccharide‐induced inflammation contributes to cognitive impairment and white matter lesion progression in diet‐induced obese mice with chronic cerebral hypoperfusion},
journal = {CNS Neuroscience & Therapeutics},
year = {2023},
doi = {10.1111/cns.14301}
}
EUVIMED